Last reviewed · How we verify
DS-3201b
At a glance
| Generic name | DS-3201b |
|---|---|
| Sponsor | Daiichi Sankyo |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Diarrhea
- Fatigue
- Back pain
- Anorexia
- Decreased appetite
- Dizziness
- Headache
- Anxiety
- Alopecia
- Rash
- Increased tendency to bruise
- Tachycardia
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DS-3201b CI brief — competitive landscape report
- DS-3201b updates RSS · CI watch RSS
- Daiichi Sankyo portfolio CI